Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,964 Cardiology
clinical trials

Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Commonwealth University/Medical College of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
Dartmouth-Hitchcock
mi
from
Lebanon, NH
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
UC San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program: Platelet Sub-Study (HARP)
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
Status: Enrolling
Updated: 12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
Status: Enrolling
Updated: 12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology, Other Clinical Trial
Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies
Status: Enrolling
Updated: 12/5/2017
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Health System
mi
from
Janesville, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Hospital-Joplin
mi
from
Joplin, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Cancer Center - North
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Cancer Clinic
mi
from
Kennewick, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Radiation Oncology Resource Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Elizabeth Regional Medical Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Mason Lynnwood Medical Center
mi
from
Lynnwood, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Idaho Urologic Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Hematology and Oncology PA
mi
from
Newark, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Assarian Cancer Center
mi
from
Novi, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Olathe Medical Center
mi
from
Olathe, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Harrison HealthPartners Hematology and Oncology-Poulsbo
mi
from
Poulsbo, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Mary - Corwin Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MultiCare Good Samaritan Hospital
mi
from
Puyallup, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Spectrum Health Reed City Hospital
mi
from
Reed City, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Roseville
mi
from
Roseville, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-South Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Marie Yeager Cancer Center
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Salina Regional Health Center.
mi
from
Salina, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Jewish Hospital Medical Center South
mi
from
Shepherdsville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Missouri Baptist Sullivan Hospital
mi
from
Sullivan, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care Specialists of Illinois-Swansea
mi
from
Swansea, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Research Center-Northwest Medical Plaza
mi
from
Tacoma, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Thornton
mi
from
Thornton, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Vallejo
mi
from
Vallejo, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UHHS Westlake Medical Center
mi
from
Westlake, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Regional Cancer System-Yelm
mi
from
Yelm, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush-Copley Healthcare Center
mi
from
Yorkville, IL
Click here to add this to my saved trials
Ischemia-Reperfusion Injury Clinical Trial
Remote Ischemic Conditioning Using the autoRIC
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Red Light Treatment in Peripheral Artery Disease
Status: Enrolling
Updated: 2/5/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
HeartPlace
mi
from
Bedford, TX
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Hospital Network
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Methodist Physicians Clinic Heart Consultants
mi
from
Omaha, NE
Click here to add this to my saved trials
Heart Disease Congenital Clinical Trial
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)
Status: Enrolling
Updated: 2/12/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Neurology, Reproductive Clinical Trial
Treatment of Brain AVMs (TOBAS) Study
Status: Enrolling
Updated: 2/12/2018
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Comparative Study of Subjects Past Their Final Follow-ON Visit
Status: Enrolling, Phase
Updated: 12/31/1969
ISCI/University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone
mi
from
New York, NY
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Swedish Medical Center Cherry Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Intracranial Aneurysm Clinical Trial
Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
CONGESTIVE HEART FAILURE Clinical Trial
Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Clinical Trial
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Status: Enrolling, Phase II
Updated: 3/20/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study
Status: Enrolling
Updated: 3/21/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
River City Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
1 … 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 … 120